Real-World Analysis of Treatment Delays in Metastatic Non-Small Cell Lung Cancer: Demographic, Clinical, and Payer Drivers
Variations in Lines of Treatment and Clinical Outcomes in US Health System Patients with Locally Advanced, Inoperable or Metastatic Triple Negative Breast Cancer (la/m TNBC)
Cost Impact of Disease Progression to Metastases in Patients with Gastric or Gastroesophageal Junction Cancer in the USA (Not Yet Submitted or Accepted)
Treatment Patterns, Health Care Resource Utilization and Clinical Outcomes among patients with Extensive-Stage Small Cell Lung Cancer
Real-World Clinical Characteristics and Treatment Patterns Among Patients with Unresectable Hepatocellular Carcinoma Amenable to Locoregional Therapy in the United States
Changing Treatment Paradigms and Unmet Needs in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Metastatic Breast Cancer (mBC): Results from Health Records Data
Real-World Treatment Patterns and Clinical Outcomes for Patients with Metastatic Triple-Negative Breast Cancer (mTNBC) in the United States: an Electronic Health Records Observational Study
Evolving Treatment Paradigms and Unmet Needs in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2-), PIK3CA-Mutated Metastatic Breast Cancer (mBC): Results from Real-World U.S. Health Records Data
Real-World Clinical Practice PIK3CA Biomarker Testing Patterns in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2-) Metastatic Breast Cancer (mBC)
Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations
